Overview Hematopoietic cell transplantation (HCT) is an essential component of therapy for
various malignant and nonmalignant conditions and provides the only curative modality for …

We analyzed the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) over
the past 2 decades. Between 1992 and 2009, 953 patients were treated with HSCT, mainly …

One hundred and fifty-four patients received allogeneic stem cell transplantations from HLA-
matched siblings for various hematological disorders from July 2001 to September 2006 …

Allogeneic hematopoietic cell transplantation (HCT) represents an important therapy for
many hematological and some epithelial malignancies, and for a spectrum of nonmalignant …

“In the 1960s in particular and even into the 1970s, there were very responsible physicians
who said this would never work,” E. Donnall Thomas, the father of bone marrow …

High-dose treatments with autologous stem cell support have increasingly been used to
improve the treatment results of a variety of haematological and nonhaematological …

Background: Long-term survivors of allogeneic hematopoietic stem cell transplantation
(alloHSCT) are at a substantial risk of developing medical late effects. We aimed to …

Cell Transplantation for Hematologic Malignancies edited by Robert J. Soiffer, the authors of
22 chapters pro- subsequent infections and organ damage. The severity of GVHD in …

The first hematopoietic stem cell transplantation (HSCT), the replacement of the
hematopoietic system, by hematopoietic stem cells from the patient (autologous HSCT) or …

Allogeneic haematopoietic stem cell transplantation (allo-SCT) is an established treatment
of haematological malignancies and other immunohaematopoietic disorders. The use of …